Pacific Biosciences Of California (PACB) Other Non-Current Liabilities (2012 - 2026)
Pacific Biosciences Of California's quarterly Other Non-Current Liabilities came in at $8.0 million in Q1 2026, up 1365.2% quarter-over-quarter from $546000.0 in Q4 2024.
Pacific Biosciences Of California has reported Other Non-Current Liabilities for 13 years, with the latest figure at $8.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $8.0 million; the trailing twelve-month figure through Mar 2026 stood at $8.0 million (changed N/A YoY), and the FY2024 full-year result was $546000.0, down 97.21% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $8.0 million, up from $546000.0 in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $186.3 million in Q2 2023, with the low at $546000.0 in Q4 2024.
- Average Other Non-Current Liabilities over 4 years is $70.9 million, with a median of $19.5 million recorded in 2024.
- Year-over-year, Other Non-Current Liabilities soared 22327.39% in 2022 and sank 99.59% in 2024.
- Tracing PACB's Other Non-Current Liabilities over 4 years: stood at $1.3 million in 2022, then soared by 1403.85% to $19.6 million in 2023, then tumbled by 97.21% to $546000.0 in 2024, then soared by 1365.2% to $8.0 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $8.0 million (Q1 2026), $546000.0 (Q4 2024), and $751000.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.00 Mn |
| Dec 31, 2024 | 546,000.00 |
| Sep 30, 2024 | 751,000.00 |
| Jun 30, 2024 | 19.48 Mn |
| Mar 31, 2024 | 751,000.00 |
| Dec 31, 2023 | 19.55 Mn |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 186.33 Mn |
| Mar 31, 2023 | 184.35 Mn |
| Dec 31, 2022 | 1.30 Mn |
| Sep 30, 2022 | 167.50 Mn |
| Jun 30, 2022 | 163.22 Mn |
| Mar 31, 2022 | 168.65 Mn |
| Dec 31, 2021 | 169.72 Mn |
| Sep 20, 2021 | 200.00 Mn |
| Jun 30, 2021 | 752,000.00 |
| Mar 31, 2021 | 752,000.00 |
| Dec 31, 2020 | 752,000.00 |
| Dec 31, 2018 | 16,000.00 |
| Sep 30, 2018 | 28,000.00 |
| Jun 30, 2018 | 40,000.00 |
| Mar 31, 2018 | 12,000.00 |
| Dec 31, 2017 | 183,000.00 |
| Sep 30, 2017 | 170,000.00 |
| Jun 30, 2017 | 15,000.00 |
| Mar 31, 2017 | 208,000.00 |
| Dec 31, 2016 | 356,000.00 |
| Sep 30, 2016 | 218,000.00 |
| Jun 30, 2016 | 1.53 Mn |
| Mar 31, 2016 | 551,000.00 |
| Dec 31, 2015 | 1.39 Mn |
| Sep 30, 2015 | 1.32 Mn |
| Jun 30, 2015 | 2.19 Mn |
| Mar 31, 2015 | 863,000.00 |
| Dec 31, 2014 | 944,000.00 |
| Sep 30, 2014 | 699,000.00 |
| Jun 30, 2014 | 699,000.00 |
| Mar 31, 2014 | 549,000.00 |
| Dec 31, 2013 | 549,000.00 |
| Sep 30, 2013 | 894,000.00 |
| Jun 30, 2013 | 894,000.00 |
| Dec 31, 2012 | 2.15 Mn |